Showing results (181-190 of 406) with videos related to

Sort By:
Pageof 41
Blood Advances|May 10, 2023
Final analysis of carfilzomib, dexamethasone, and daratumumab vs carfilzomib and dexamethasone in the CANDOR studySaad Z Usmani, Hang Quach, Maria-Victoria Mateos, et al.
Clinical Lymphoma, Myeloma & Leukemia|January 11, 2024
Characterization and Outcomes of Spanish Patients With Relapsed/Refractory Multiple Myeloma Included in the LocoMMotion StudyMaria-Victoria Mateos, Katja Weisel, Joris Diels, et al.
Leukemia & Lymphoma|November 9, 2018
A comparison of the efficacy of immunomodulatory-free regimens in relapsed or refractory multiple myeloma: a network meta-analysisKatja Weisel, Pieter Sonneveld, Andrew Spencer, et al.
Frontiers in Oncology|January 21, 2025
Outcome of critically ill patients receiving systemic chemotherapy on the intensive care unitPanagiotis Karagiannis, Felix Klingler, Viktor Arelin, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 14, 2025
Health-Related Quality of Life in Patients With Relapsed/Refractory Multiple Myeloma Treated With Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone: An Analysis of Patient-Reported Outcomes From the Phase 3 CANDOR TrialKatja Weisel, Maria-Victoria Mateos, Ola Landgren, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 15, 2026
Malignancy-Associated Hemophagocytic Lymphohistiocytosis: Clinical Characteristics, Treatment Patterns, and Survival Outcomes in a Tertiary Care Center CohortRicardo Kosch, Winfried Alsdorf, Paymon Ahmadi, et al.
Rheumatology International|October 12, 2013
High prevalence of psoriatic arthritis in dermatological patients with psoriasis: a cross-sectional studyJoerg C Henes, Eva Ziupa, Michael Eisfelder, et al.
Blood|September 25, 2003
Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cellsSilke Appel, Andreas M Boehmler, Frank Grünebach, et al.
Lung Cancer (Amsterdam, Netherlands)|January 20, 2020
Cryobiopsy increases the EGFR detection rate in non-small cell lung cancerMaik Haentschel, Michael Boeckeler, Ahmed Ehab, et al.
Frontiers in Medicine|November 25, 2021
Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and MyelomaFranziska Brauneck, Pauline Weimer, Julian Schulze Zur Wiesch, et al.
Pageof 41